HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?

HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...

Полное описание

Библиографические подробности
Главные авторы:	Goulbourne, C, Vaux, D
Формат:	Journal article
Язык:	English
Опубликовано:	Portland Press 2010

Схожие документы

The structural basis of ZMPSTE24-dependent laminopathies
по: Quigley, A, и др.
Опубликовано: (2013)

The structural basis of ZMPSTE24-dependent laminopathies.
по: Quigley, A, и др.
Опубликовано: (2013)

Prelamin A and ZMPSTE24 in premature and physiological aging
по: Howard J. Worman, и др.
Опубликовано: (2023-12-01)

ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
по: Moritz Messner, и др.
Опубликовано: (2020-08-01)

Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
по: Jemima Barrowman, и др.
Опубликовано: (2012-01-01)

Acquired and Inherited Lipodystrophies
Опубликовано: (2004-06-01)

Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy
по: Aline Francielle Mota Segatto, и др.
Опубликовано: (2011-08-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
по: N. Sunil Kumar, и др.
Опубликовано: (2015-07-01)

Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity
по: Robert J. Stott-Marshall, и др.
Опубликовано: (2022-02-01)

运用二代测序技术产前诊断ZMPSTE24基因突变
по: 麦明琴, и др.
Опубликовано: (2017-01-01)

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
по: William S. Hambright, и др.
Опубликовано: (2023-01-01)

Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
по: Ayako Nagayama, и др.
Опубликовано: (2021-05-01)

Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24-deficient mice
по: Jie Zhang, и др.
Опубликовано: (2024-05-01)

HIV-1 protease as a target for antiretroviral therapy
по: Windsor, Ian William.
Опубликовано: (2019)

Acquired lipodystrophy following use of pembrolizumab
по: Maya Weitzen, и др.
Опубликовано: (2024-12-01)

Acquired partial lipodystrophy associated with varicella
по: Zafer Kurugöl, и др.
Опубликовано: (2009-12-01)

The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa
по: Honoré Kalombayi Tshamala, и др.
Опубликовано: (2019-01-01)

Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
по: Pere Domingo, и др.
Опубликовано: (2010-11-01)

Influence of the duration of antiretroviral use on insulin resistance among people living with HIV with lipodystrophy
по: Thiago Rodrigues Faria Vitorazzi, и др.
Опубликовано: (2018-12-01)

Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24.
по: Kaitlin M Wood, и др.
Опубликовано: (2020-01-01)

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B
по: Kamsi O. Odinammadu, и др.
Опубликовано: (2023-12-01)

Lipodystrophy syndrome in HIV /
по: Wanke, Christine A., и др.
Опубликовано: (2003)

The Place of protease inhibitors in antiretroviral treatment
по: S.B. Tenore, и др.

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
по: Bwakura-Dangarembizi, M, и др.
Опубликовано: (2015)

Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24
по: Mehmood, S, и др.
Опубликовано: (2016)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
по: Spear, ED, и др.
Опубликовано: (2018)

Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation
по: Jinlong Suo, и др.
Опубликовано: (2023-05-01)

A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy
по: Damien Galant, и др.
Опубликовано: (2016-04-01)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
по: Eric D. Spear, и др.
Опубликовано: (2018-07-01)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch
по: Simeon Eche, и др.
Опубликовано: (2021-03-01)

Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.
по: Cordula Frohoff, и др.
Опубликовано: (2011-02-01)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
по: Musiime, V, и др.
Опубликовано: (2014)

Barraquer–Simons Lipodystrophy Syndrome in an Otherwise Normal Child: A Rare Case of Acquired Partial Lipodystrophy
по: Kananbala Sahu, и др.
Опубликовано: (2021-01-01)

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen
по: Mohammed Mitha, и др.
Опубликовано: (2010-11-01)

Overview of HIV-related lipodystrophy
по: T Marie Rossouw, и др.
Опубликовано: (2013-02-01)

Hiv-associated lipodystrophy and exercise
по: E. Mutimura, и др.
Опубликовано: (2006-02-01)

Restrictive Dermopathy Due to ZMPSTE24 Mutation: A Case Report with a Novel Finding of Corpus Callosum Agenesis
по: Minu Jose Chiramel, и др.
Опубликовано: (2024-01-01)

Deficiency in ZMPSTE24 and resulting farnesyl–prelamin A accumulation only modestly affect mouse adipose tissue stores[S]
по: Patrick J. Heizer, и др.
Опубликовано: (2020-03-01)

Inherited and acquired lipodystrophies: molecular-genetic and autoimmune mechanisms
по: Ekaterina L. Sorkina, и др.
Опубликовано: (2018-04-01)

Acquired partial lipodystrophy: An atypical presentation with therapeutic challenge
по: Komali Garlapati, и др.
Опубликовано: (2015-01-01)